These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30834834)

  • 1. In Vitro, In Silico and Ex Vivo Studies of Dihydroartemisinin Derivatives as Antitubercular Agents.
    Kalani K; Alam S; Chaturvedi V; Singh S; Khan F; Srivastava SK
    Curr Top Med Chem; 2019; 19(8):633-644. PubMed ID: 30834834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroartemisinin and its Analogs: A New Class of Antitubercular Agents.
    Kalani K; Chaturvedi V; Trivedi P; Tondon S; Srivastava SK
    Curr Top Med Chem; 2019; 19(8):594-599. PubMed ID: 30836916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, in vitro and in silico studies of 2, 3-diaryl benzofuran derivatives as antitubercular agents.
    Bhukya B; Shukla A; Chaturvedi V; Trivedi P; Kumar S; Khan F; Negi AS; Srivastava SK
    Bioorg Chem; 2020 Jun; 99():103784. PubMed ID: 32361184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of dihydroartemisinin-fluoroquinolone conjugates as a novel type of potential antitubercular agents.
    Zhou FW; Lei HS; Fan L; Jiang L; Liu J; Peng XM; Xu XR; Chen L; Zhou CH; Zou YY; Liu CP; He ZQ; Yang DC
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1912-7. PubMed ID: 24684842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tubercular agents from Glycyrrhiza glabra.
    Kalani K; Chaturvedi V; Alam S; Khan F; Srivastava SK
    Curr Top Med Chem; 2015; 15(11):1043-9. PubMed ID: 25786503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-benzylidene-4-chromanones: a novel cluster of anti-tubercular agents.
    Das U; Lorand T; Dimmock SG; Perjesi P; Dimmock JR
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):259-63. PubMed ID: 24939095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates.
    Ribeiro RCB; de Marins DB; Di Leo I; da Silva Gomes L; de Moraes MG; Abbadi BL; Villela AD; da Silva WF; da Silva LCRP; Machado P; Bizarro CV; Basso LA; Cristina de Moraes M; Ferreira VF; da Silva FC; Nascimento V
    Eur J Med Chem; 2021 Jan; 209():112859. PubMed ID: 33010635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
    Venugopala KN; Chandrashekharappa S; Deb PK; Tratrat C; Pillay M; Chopra D; Al-Shar'i NA; Hourani W; Dahabiyeh LA; Borah P; Nagdeve RD; Nayak SK; Padmashali B; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Haroun M; Shashikanth S; Mohanlall V; Mailavaram R
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1472-1487. PubMed ID: 34210233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv.
    Sunduru N; Gupta L; Chaturvedi V; Dwivedi R; Sinha S; Chauhan PM
    Eur J Med Chem; 2010 Aug; 45(8):3335-45. PubMed ID: 20452706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation.
    Chen R; Zhang H; Ma T; Xue H; Miao Z; Chen L; Shi X
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2635-2637. PubMed ID: 31358466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brevifoliol and its Analogs: A New Class of Anti-tubercular Agents.
    Bhukya B; Alam S; Chaturvedi V; Trivedi P; Kumar S; Khan F; Negi AS; Srivastava SK
    Curr Top Med Chem; 2021; 21(9):767-776. PubMed ID: 32484109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
    Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
    Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
    Penta A; Franzblau S; Wan B; Murugesan S
    Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzofuran-isatin hybrids tethered via different length alkyl linkers and their in vitro anti-mycobacterial activities.
    Gao F; Chen Z; Ma L; Qiu L; Lin J; Lu G
    Bioorg Med Chem; 2019 Jun; 27(12):2652-2656. PubMed ID: 30992202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of (-)-Camphene Derivatives Against Mycobacterium tuberculosis in Acidic pH.
    de Carvalho HC; Ieque AL; Valverde TL; Baldin VP; Meneguello JE; Campanerut-Sá PAZ; Vandresen F; Ghiraldi Lopes LD; Passos Souza MR; Santos NCS; Dias Siqueira VL; Caleffi-Ferracioli KR; Lima Scodro RB; Cardoso RF
    Med Chem; 2021; 17(5):485-492. PubMed ID: 31702530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives.
    Lopes-Ortiz MA; Panice MR; Borges de Melo E; Ataide Martins JP; Baldin VP; Agostinho Pires CT; Caleffi-Ferracioli KR; Dias Siqueira VL; Bertin de Lima Scodro R; Sarragiotto MH; Cardoso RF
    Eur J Med Chem; 2020 Feb; 187():111935. PubMed ID: 31816556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.